These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 19545988)

  • 1. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids from fish oils and cardiovascular disease.
    Holub DJ; Holub BJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease prevention and treatment.
    von Schacky C
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK; Kostkiewicz M
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids and cardiovascular disease.
    von Schacky C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors.
    Ryan AS; Keske MA; Hoffman JP; Nelson EB
    Am J Ther; 2009; 16(2):183-92. PubMed ID: 19145206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ; Milani RV; Mehra MR; Ventura HO
    J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary reference intakes for DHA and EPA.
    Kris-Etherton PM; Grieger JA; Etherton TD
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):99-104. PubMed ID: 19525100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
    Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
    Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
    Agren JJ; Hänninen O; Julkunen A; Fogelholm L; Vidgren H; Schwab U; Pynnönen O; Uusitupa M
    Eur J Clin Nutr; 1996 Nov; 50(11):765-71. PubMed ID: 8933125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What can we expect from omega-3 fatty acids?
    Chan EJ; Cho L
    Cleve Clin J Med; 2009 Apr; 76(4):245-51. PubMed ID: 19339640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of Atlantic salmon in the Chinese diet reduces cardiovascular disease risk markers in dyslipidemic adult men.
    Zhang J; Wang C; Li L; Man Q; Song P; Meng L; Du ZY; Frøyland L
    Nutr Res; 2010 Jul; 30(7):447-54. PubMed ID: 20797476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review.
    Weber P; Raederstorff D
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):28-37. PubMed ID: 10812585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling.
    Brownawell AM; Harris WS; Hibbeln JR; Klurfeld DM; Newton I; Yates A
    Nutr Rev; 2009 Jul; 67(7):391-7. PubMed ID: 19566599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.